HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Usefulness and validation of the survival posT TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis.

Abstract
Surgical risk scores fail to accurately predict mortality after transcatheter aortic valve implantation (TAVI). The aim of this study was to develop and validate a dedicated risk score for accurate estimation of mortality risk in these patients. All consecutive patients who underwent TAVI at 6 international institutions were enrolled. Predictors for 1-year all-cause mortality were identified by means of Cox multivariate analysis and incorporated in a prediction score. Accuracy of the score was derived and externally validated for 30-day and 1-year mortality. The net classification improvement compared with the Society of Thoracic Surgeons (STS) score was appraised. A total of 1,064 patients constituted the derivation cohort and 180 patients constituted the external validation cohort. A total of 165 patients (15%) died at 1-year follow-up. Previous stroke (odds ratio [OR] 1.80, 1.4 to 3), inverse of renal clearance (OR 8, 6 to 14), and systolic pulmonary arterial pressure ≥50 mm Hg (OR 2.10, 1.5 to 3) were independently related to 1-year mortality. Area under the curve (AUC) of the survival post TAVI (STT) for 1-year mortality was 0.68 (0.62 to 0.71). At 30 days, 65 patients (7%) had died and the AUC for the STT at this time point was 0.66 (0.64 to 0.75). In the external validation cohorts, the AUC of the STT were 0.66 (0.56 to 0.7) for 30-day and 0.67 (0.62 to 0.71) for 1-year mortality. Net reclassification improvement for STT compared with STS was 31% (p <0.001) for 30-day mortality and 14% (p <0.001) for 1-year mortality. In conclusion, the STT score represents an easy and accurate tool to assess the risk of short-term and mid-term mortality in patients undergoing TAVI.
AuthorsFabrizio D'Ascenzo, Davide Capodanno, Giuseppe Tarantini, Freek Nijhoff, Cristina Ciuca, Marco Luciano Rossi, Nedy Brambilla, Marco Barbanti, Massimo Napodano, Pieter Stella, Francesco Saia, Giuseppe Ferrante, Corrado Tamburino, Valeria Gasparetto, Pierfrancesco Agostoni, Antonio Marzocchi, Patrizia Presbitero, Francesco Bedogni, Enrico Cerrato, Pierluigi Omedè, Federico Conrotto, Stefano Salizzoni, Giuseppe Biondi Zoccai, Sebastiano Marra, Mauro Rinaldi, Fiorenzo Gaita, Maurizio D'Amico, Claudio Moretti
JournalThe American journal of cardiology (Am J Cardiol) Vol. 114 Issue 12 Pg. 1867-74 (Dec 15 2014) ISSN: 1879-1913 [Electronic] United States
PMID25438915 (Publication Type: Journal Article, Multicenter Study, Observational Study)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Topics
  • Aged, 80 and over
  • Aortic Valve Stenosis (mortality, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Italy (epidemiology)
  • Male
  • Odds Ratio
  • Postoperative Complications (epidemiology)
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Assessment (methods)
  • Risk Factors
  • Survival Rate (trends)
  • Time Factors
  • Transcatheter Aortic Valve Replacement (adverse effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: